» Articles » PMID: 35467743

Why Does the Omicron Variant Largely Spare Olfactory Function? Implications for the Pathogenesis of Anosmia in Coronavirus Disease 2019

Overview
Journal J Infect Dis
Date 2022 Apr 25
PMID 35467743
Authors
Affiliations
Soon will be listed here.
Abstract

The omicron variant of severe acute respiratory syndrome coronavirus 2 causes much less olfactory dysfunction than the previous variants. There are several potential mechanisms for how omicron may change tissue tropism and spare olfactory function. The new mutations make omicron more hydrophobic and alkaline than previous variants, which may reduce penetration of the mucus layer. Overall, the new mutations minimally change receptor binding affinity, but entry efficiency into host cells is reduced in cells expressing transmembrane serine protease 2 (TMPRSS2). Because the support cells in the olfactory epithelium abundantly express TMPRSS2, these main target cells in the olfactory epithelium may become infected less by the new omicron variant.

Citing Articles

Polyunsaturated Fatty Acids as Potential Treatments for COVID-19-Induced Anosmia.

Wang Y, Lin C, Huang C Biomedicines. 2024; 12(9).

PMID: 39335598 PMC: 11428228. DOI: 10.3390/biomedicines12092085.


Frequency of SARS-CoV-2 Infections among Healthcare Workers in Germany: 3-Year Follow-Up Study.

Stammkotter C, Thummler L, Korth J, Marenbach B, Brass P, Horn P Infect Dis Rep. 2024; 16(4):615-627.

PMID: 39051247 PMC: 11270172. DOI: 10.3390/idr16040047.


Palmitoylethanolamide and Luteolin for Postinfectious Olfactory Disorders: How Clinically Meaningful Is Its Effect?.

Gellrich J, Czaplewski L, Hahner A, Hummel T ORL J Otorhinolaryngol Relat Spec. 2024; 86(3-4):118-123.

PMID: 38861957 PMC: 11651318. DOI: 10.1159/000539651.


Long COVID: From olfactory dysfunctions to viral Parkinsonism.

Pandey S, Bapat V, Abraham J, Abraham N World J Otorhinolaryngol Head Neck Surg. 2024; 10(2):137-147.

PMID: 38855289 PMC: 11156689. DOI: 10.1002/wjo2.175.


Cognitive deficits and cortical volume loss in COVID-19-related hyposmia.

Gezegen H, Ay U, Samanci B, Kurt E, Yoruk S, Medetalibeyoglu A Eur J Neurol. 2024; 32(1):e16378.

PMID: 38850121 PMC: 11618109. DOI: 10.1111/ene.16378.


References
1.
. SARS-CoV-2 B.1.1.529 (Omicron) Variant - United States, December 1-8, 2021. MMWR Morb Mortal Wkly Rep. 2021; 70(50):1731-1734. PMC: 8675659. DOI: 10.15585/mmwr.mm7050e1. View

2.
Hoffmann M, Kruger N, Schulz S, Cossmann A, Rocha C, Kempf A . The Omicron variant is highly resistant against antibody-mediated neutralization: Implications for control of the COVID-19 pandemic. Cell. 2022; 185(3):447-456.e11. PMC: 8702401. DOI: 10.1016/j.cell.2021.12.032. View

3.
Armando F, Beythien G, Kaiser F, Allnoch L, Heydemann L, Rosiak M . SARS-CoV-2 Omicron variant causes mild pathology in the upper and lower respiratory tract of hamsters. Nat Commun. 2022; 13(1):3519. PMC: 9207884. DOI: 10.1038/s41467-022-31200-y. View

4.
Graham M, Sudre C, May A, Antonelli M, Murray B, Varsavsky T . Changes in symptomatology, reinfection, and transmissibility associated with the SARS-CoV-2 variant B.1.1.7: an ecological study. Lancet Public Health. 2021; 6(5):e335-e345. PMC: 8041365. DOI: 10.1016/S2468-2667(21)00055-4. View

5.
Hintschich C, Niv M, Hummel T . The taste of the pandemic-contemporary review on the current state of research on gustation in coronavirus disease 2019 (COVID-19). Int Forum Allergy Rhinol. 2021; 12(2):210-216. PMC: 8653126. DOI: 10.1002/alr.22902. View